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Different anchoring groups have been studied with the aim of covalently binding organic linkers to the 
surface of alumina ceramic foams. The results suggested that a higher degree of functionalisation was 
achieved with a pyrogallol derivative - as compared to its catechol analogue - based on the XPS analysis 
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of the ceramic surface. The conjugation of organic ligands to the surface of these alumina materials was 
corroborated by DNP-MAS-NMR measurements. 
Ceramic foam, functionalisation, XPS, DNP-MAS-NMR, biomaterials, pyrogallol moiety. 
Introduction 
While today's gold standard to treat bone defects is still autologous iliac crest bone grafting, the 
development of synthetic bone graft materials appears as an appealing alternative. Following the 
foaming procedure developed by Gonzenbach et al.,1 highly porous alumina can be produced into 
desired shapes to fill, for example, bone defects and provide mechanical resistance to the graft. The pore 
size and interconnectivity of this new material can be controlled during the foaming process and can be 
tuned accordingly.2 The foams feature a macrostructure with pores between 100-350 µm which 
promotes osteogenesis, cells and ions transport for generation of bone tissue and a microstructure with 
pores <20 µm that favours the neovascularisation and fiberblast ingrowth.3 Nevertheless, in order to 
promote efficient tissue regeneration within the biomaterial, seeding of the scaffold with osteogenic 
cells4 or osteoinductive growth factors4,5 may be required. In this context, the biocompatibility of these 
new open-porous alumina ceramic scaffolds for human fetal osteoblasts has been demonstrated in vitro.6 
Another challenge associated with large bone substitutes is the necessity to develop a functional 
vascular system within the biomaterials. Several studies have shown that cell proliferation and 
mineralized tissue formation is often restricted to a zone of 120-250 µm from the scaffold surface.7 
Even when uniform initial seeding is achieved, the cells within the scaffold might either die or migrate 
toward the periphery of the scaffold to be exposed to higher levels of oxygen and nutrients unless a 
vascularised system is also present within the scaffold to ensure the cells needs.8 Angiogenesis for the 
vascularisation of the new graft can be promoted by the presence of progenitor cells (e.g. human 
umbilical vein endothelial cells (HUVEC)4b,7a,9 and/or bioactive molecules (e.g. vascular endothelial 
growth factor (VEGF))4b,5,7a,9,10 that could be covalently attached to the ceramic through a small spacer 
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molecule.11  
In the course of our studies for the development of open-porous alumina scaffolds as new potential 
bone substitutes,12 we envisaged the chemical functionalisation of the alumina matrix by small organic 
ligands to promote both the formation of blood vessels and the adhesion of bone cell progenitors to the 
material. Among the simple chemical groups that have been proposed for adhesion on alumina, 1,2-di- 
and 1,2,3-trihydroxy benzene (catechol and pyrogallol) present efficient adsorption on the material 
surface through a process of ligand exchange.13  In the present work, we demonstrate the stable 
functionalisation of open-porous alumina ceramic foams with organic ligands deriving from catechol 
and pyrogallol. Chemical modification of the material surface was monitored by X-ray Photoelectron 
Spectroscopy (XPS), a technique classically used for the surface characterisation of various materials 
including ceramics,14 and was confirmed by DNP-MAS-NMR measurements. 
Results and discussion 
Preparation of organic ligands for the functionalization of open-porous alumina scaffolds 
Our first challenge was to produce the proper organic ligands to bind to the ceramic foam in a stable 
and efficient manner. Two anchoring moieties were considered – catechol and pyrogallol – since they 
can complex the aluminium present in the inorganic matrix and act as adhesive functionalities.13 The 
ligands 1 (catechol derivative) and 2 (pyrogallol derivative) were chosen as models while 3 was used as 
a negative control (Figure 1). 
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Figure 1. Linker 1 (catechol derivative), linker 2 (pyrogallol derivative) and 3 (negative control). 
The synthesis of these molecules was carried out following the synthetic route shown in Scheme 1. 
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Copper catalyzed azide-alkyne cycloaddition between azide 415 and alkyne 516 gave the key 
intermediate 6 in 89% yield. After activation of the carboxylic acids 7-9 with oxalyl chloride/DMF 
(cat), the resulting acyl chlorides were coupled with amine 6 to deliver the corresponding amides in high 
yields. Final cleavage of the acetyl moieties in molecules 10-11 with hydrazine afforded the linkers 1 
and 2 in 78 and 86% crude yields, respectively. 
 Scheme 1. Synthesis of linkers 1-3.  
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High-purity samples of 1-3 for conjugation studies were obtained after purification by reverse-phase 
HPLC. 
Chemical modification of open-porous alumina ceramics and characterization of the functionalised 
materials 
The ceramic foams at hand were produced according to a procedure published elsewhere.2b For this 
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study, we selected the ceramics presenting the composition and pore characteristics depicted in Table 1.  
 
Table 1. Physical characteristics of ceramics S1, S2 and S3. † Reference 4. ‡ Determined by XPS. 
Ceramic S1 S2 S3 
Average 
pore size (µm) † 
170 170 460 
Average pore 
opening size (µm)† 
50 50 95 
Porosity (vol %)† 76 76 86 
Al/Ca ratio‡ 7.4 33.4 8.4 
 
The functionalisation of the ceramic S1-S3 surface with the linkers 1-3 was performed with a 1 mM 
aqueous solution of the corresponding linker, at room temperature for 16 h (for experimental details, see 
supporting information). After removal of the excess non-bound ligands by thorough washings with 
water, the samples were dried under vacuum and subsequently analysed by XPS. The fluorine content 
was determined and considered as measurement of functionalisation. For each ceramic, four samples 
were studied: untreated ceramic (sample A), negative control – incubated with 3 – (sample B), ceramic 
functionalised with linker 1 (sample C) and ceramic functionalised with linker 2 (sample D). 
According to the survey scan spectra of sample A-S1 (Figure 2, a), the elements of C, Ca, O and Al 
were found, of which the elements Ca, O and Al arose from the components of the ceramic itself since 
ceramic foams are made of alumina and calcium aluminate. The peaks associated with N and F in 
samples C-S1 and D-S1 after the functionalisation process demonstrated the presence of the linkers 1 
and 2 respectively on the ceramic surface (Figure 2, c and d). Furthermore, the peaks at 293 eV and 
688.5 eV are characteristics of a C1s and F1s from a trifluoromethyl group, respectively, proving 
undoubtedly the presence of the linkers at the surface of the ceramic scaffolds. No significant difference 
was observed between the untreated ceramic (A-S1) and the negative control (B-S1), which highlighted 
that the catechol or pyrogallol moieties are essential for the binding to the alumina foams (Figure 2, a 
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and b).17 Similar observations were made for the S2-S3 (data not shown). 
 
Figure 2. XPS wide survey spectra. (a) untreated ceramic A-S1, (b) negative control B-S1, (c) linker 1-
functionalised ceramic foam C-S1, (d) linker 2-functionalised ceramic foam D-S1. Note the presence of 
F and N peaks in samples C-S1 and D-S1 and lack of them in sample B-S1 (negative control). 
Although XPS is widely used as unique technique for characterisation of surfaces, we decided to 
confirm the results using the cutting-edge analytical technique DNP-MAS-NMR.18 For this experiment 
we used 3,4,5-trihydroxybenzamide (12) as a model compound for gallate derived organic ligands. Even 
with a relatively low functionalisation degree, the DNP enhanced 13C-CP/MAS NMR spectrum of the 
functionalised alumina (Figure 3) clearly shows the signals from the organic component 12, in 
agreement with the XPS results (for experimental details, see supporting information). The signal 
enhancement reached by DNP (εDNP = ca. 10) allows to obtain good signal/noise ratio and clear spectra, 
which was not possible using the standard 13C-CP/MAS NMR.  
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Figure 3. DNP-MAS-13C NMR measurements. (a) pure 3,4,5-trihydroxybenzamide, (b) alumina 
functionalized with 3,4,5-trihydroxybenzamide, (c) untreated alumina 
Influence of the composition and microstructure of the ceramic foams on the chemical 
functionalisation 
XPS data of the untreated ceramics showed that S2 has a much higher Al content, as compared to the 
two other ceramic foams (S1 and S3), which was in agreement with the preparation method1 (Table 2, 
entries 1-3). This higher Al content did not lead to an increased degree of functionalisation since at the 
same pore size, the F/Al ratio was lower in S2 than in S1 (entry 8 vs 7; entry 11 vs 10). This could be 
explained by the fact that the number of available Al sites may be limited by cluttering (an excess of 
linker was confirmed after incubation by analysis of the supernatant).  
Table 2. Al/Ca and F/Al ratios determined by XPS 
entry ceramic linker Al/Ca F/Al 
1 S1 ø 7.4 ± 2.3 - 
2 S2 ø 33.4 ± 10.5 - 
3 S3 ø 8.4 ± 2.6 - 
4 S1 3 5.5 ± 1.7 - 
5 S2 3 43.2 ± 13.6 - 
6 S3 3 9.5 ± 3.0 - 
7 S1 1 7.5 ± 2.4 0.4 ± 0.1 
8 S2 1 50.5 ± 15.9 0.2 ± 0.1 
9 S3 1 9.6 ± 3.0 0.3 ± 0.1 
10 S1 2 7.9 ± 2.5 1.1 ± 0.3 
11 S2 2 27.7 ± 8.7 0.5 ± 0.1 
12 S3 2 9.6 ± 3.0 0.7 ± 0.2 
 
Bigger pores induced smaller specific surface available for functionalisation and, at the same chemical 
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composition of the ceramic, the F/Al ratio found was lower in S3 than in S1 (entry 7 vs 9; 10 vs 12). 
Finally, the higher degree of functionalisation with linker 2 indicated that the pyrogallol moiety is more 
efficient for the complexation of aluminium contained in the ceramic matrices than the catechol moiety 
(entry 7 vs 10; 8 vs 11; 9 vs 12). 
Conclusions 
The incubation of open-porous alumina scaffolds with organic ligands containing pyrogallol or 
catechol functionalities allowed their stable anchoring to the surface of the material. XPS analysis of the 
functionalised ceramic foams indicated than the pyrogallol moiety offers the highest degree of 
conjugation to the inorganic matrix. The chemical modification of the alumina matrices was confirmed 
by DNP-MAS-NMR measurements. Interestingly, the resulting binding showed to be stable after 
thorough washings with water (see protocol in supporting information). Furthermore, the conditions for 
the functionalisation are bio-compatible which should allow further conjugation of the ceramic foams to 
living cells.  
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